| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/28/2005 | US20050089980 Novel laccase enzyme and the gene encoding the enzyme |
| 04/28/2005 | US20050089976 Nucleotide sequences coding for the lysRI gene |
| 04/28/2005 | US20050089972 Production of porphyrins |
| 04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 04/28/2005 | US20050089969 exsulins have a molecular weight of up to 55,000 Daltons and have1 to 50 basic units of specific amino acids; therapeutic and dietetic use |
| 04/28/2005 | US20050089967 Mutant tyrosine repressor gene and utilization thereof |
| 04/28/2005 | US20050089965 Novel human secreted proteins and polynucleotides encoding the same |
| 04/28/2005 | US20050089962 Novel human ion channel proteins and polynucleotides encoding the same |
| 04/28/2005 | US20050089961 Class of alpha2delta calcium channel subunits |
| 04/28/2005 | US20050089960 Biosynthesis; immunoglobulin signal peptides; fusion proteins; for delivery to the central nervous system and eye by gene therapy; host cells |
| 04/28/2005 | US20050089959 Protoxins, cytotoxins; antibodies; cleavage via trypsin; for lysing human cancer cells |
| 04/28/2005 | US20050089958 Cytokines which induce mammalian cell apoptosis; tumor necrosis factors; cancer, gliomas |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089955 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/28/2005 | US20050089954 Gene cluster for rabelomycin biosynthesis and its use to generate compounds for drug screening |
| 04/28/2005 | US20050089951 Method for labeled amidation of biological molecule and method for analyzing biological molecule |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089938 For treatment of epilepsy, hypertension, angina pectoris, cerebral ischaemia, Parkinson's disease, insulin-dependent diabetes, and/or Lambert-Eaton myasthenic syndrome |
| 04/28/2005 | US20050089937 Morphine modulating peptide; opoid receptor modulators with effects on morphine analgesia tolerance and withdrawal; drug screening |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089927 Novel peptides for the diagnosis of schizophrenia |
| 04/28/2005 | US20050089925 43239, a novel GPCR-like molecule and uses thereof |
| 04/28/2005 | US20050089921 Controlling cell proliferative using polypeptides; antitumor, anticancer agents |
| 04/28/2005 | US20050089912 Nucleic acids having polynucleotide sequences to encode two novel splice variant isoforms of nuclear factor kappa-B, subunit 1 (NFKB1) called NFKB1sv1 and NFKB1sv2; screening for agonist and antagonist ligands to bind to the new isoforms; antiinflammatory, - carcinogenic agents; AIDS;lupus; viricides |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089908 An optimized variant of cyan fluorescent protein (oCFP) containing an amino acid other than tyrosine at position 145. |
| 04/28/2005 | US20050089892 Biiodrugs for diagnosis, drug screening, clinical trial monitoring, treatment of physiological disorders; viral disease and infection prevention; expression vectors |
| 04/28/2005 | US20050089888 Platelet glycoprotein Ib alpha variant fusion polypeptides and methods of use thereof |
| 04/28/2005 | US20050089887 Novel human ion channel proteins |
| 04/28/2005 | US20050089884 Genes coding for ketosynthase, acyl transferase, acyl carrier protein, ketoreductase, dehydratase and enoyl reductase domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, 4-amino-4-deoxychorismate (ADC) synthase or lyase |
| 04/28/2005 | US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes |
| 04/28/2005 | US20050089872 Nucleic acid molecules encoding annexins from plants |
| 04/28/2005 | US20050089871 G protein-related kinase mutants in essential hypertension |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089867 Antigen fragments for the diagnosis of toxoplasma gondii |
| 04/28/2005 | US20050089866 Identifying modulators for the treatment and prevention of diabetes, pain, obesity, nervous system, inflammatory, cell proliferative and liver disorders |
| 04/28/2005 | US20050089858 Expression vector comprising nucleotide sequences coding tumor suppressor protein for use in diagnosis and prevention of cell proliferative disorders |
| 04/28/2005 | US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders |
| 04/28/2005 | US20050089852 Microarray for use in identifying polymorphisms in hepatocyte nuclear factor-1, amylin, glucokinase and/or mitochondrial DNA which are associated with pancreatic disorders in individuals of asian descent |
| 04/28/2005 | US20050089848 Nucleotide sequences coding islet cell antigen-2 (IA21C) for use as diagnostic tools in detection of insulin-dependent diabetes mellitus |
| 04/28/2005 | US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases |
| 04/28/2005 | US20050089841 Induction of a Th1-like response in vitro |
| 04/28/2005 | US20050089840 Peptide derivative fusion inhibitors of HIV infection |
| 04/28/2005 | US20050089532 Method of protein production using mitochondrial translation system |
| 04/28/2005 | US20050089531 Two types of foreign genes inserted in such a manner as to allow the expression into two different regions in the recombinant feline herpesvirus type 1 genome |
| 04/28/2005 | US20050089529 Immunization of dairy cattle with GapC protein against Streptococcus infection |
| 04/28/2005 | US20050089527 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |
| 04/28/2005 | US20050089526 Monomeric unit of the complex containin HIV-1 gp120 and HIV-1 gp41, (ii) the gp4l has one or more mutations in its N-terminal helix, and (iii) the gp120 and gp41 are bound to each other by a disulfide bond between a cysteine residue introduced into the gp120 and a cysteine residue introduced into gp41 |
| 04/28/2005 | US20050089525 Subunit respiratory syncytial virus vaccine preparation |
| 04/28/2005 | US20050089524 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine |
| 04/28/2005 | US20050089522 Treating a bone cancer patient with a monoclonal antibody that specifically binds a RANK (receptor activator of NF- kappa B) polypeptide with specific amino acid sequence for inhibiting RANK-induced osteoclastogenesis |
| 04/28/2005 | US20050089511 Methods and compositions comprising DNA damaging agents and p53 |
| 04/28/2005 | US20050089510 Immunization against plaque forming diseases such as cardiovascular disorders with vaccines for disaggregation |
| 04/28/2005 | CA2546623A1 Cystatin c as an antagonist of tgf-.beta. and methods related thereto |
| 04/28/2005 | CA2545539A1 Alteration of fc-fusion protein serum half-lives by mutagenesis of positions 250, 314 and/or 428 of the heavy chain constant region of ig |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542684A1 Targeting compositions and preparation thereof |
| 04/28/2005 | CA2542680A1 Pharmaceutical compositions for therapeutic use |
| 04/28/2005 | CA2542618A1 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | CA2542482A1 Ztnfr14, a tumor necrosis factor receptor |
| 04/28/2005 | CA2542478A1 Method for the dissociation of the extracellular haemoglobin molecule of arenicola marina and the characterisation of the protein chains forming the molecule and the nucleotide sequences coding for said protein chains |
| 04/28/2005 | CA2542337A1 Cancer gene therapeutic drug |
| 04/28/2005 | CA2542335A1 Cancer gene therapeutic drug |
| 04/28/2005 | CA2542281A1 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 04/28/2005 | CA2542276A1 Control of es cell self-renewal and lineage specification, and medium therefor |
| 04/28/2005 | CA2542269A1 Fusion molecules comprising antigens and mhc i or ii cytoplasmic domains |
| 04/28/2005 | CA2542155A1 Poxvirus vector encoding retrovirus (eg hiv) and cytokine |
| 04/28/2005 | CA2540210A1 Transgenic rodents selectively expressing human b1 bradykinin receptor protein |
| 04/28/2005 | CA2539996A1 Prevention of incorporation of non-standard amino acids into protein |
| 04/28/2005 | CA2538722A1 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 04/28/2005 | CA2537900A1 Multiplex vaccines |
| 04/28/2005 | CA2536082A1 Therapeutic uses of chemokine variants |
| 04/28/2005 | CA2512431A1 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 04/27/2005 | EP1526184A1 Promoter sequences specific for cells of the B lymphoid lineage and pharmaceutical compositions containing the same |
| 04/27/2005 | EP1526183A2 Dimer of a peptide derived from the C-terminal sequence of human superoxide dismutase facilitating the penetration of a substance into cells and/or cell nuclei |
| 04/27/2005 | EP1526181A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia |
| 04/27/2005 | EP1526179A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia |
| 04/27/2005 | EP1526178A1 MSP-3-like family of genes |
| 04/27/2005 | EP1526175A2 Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1526140A1 Novel potassium-dependent sodium-calcium exchanger |
| 04/27/2005 | EP1525889A1 Liquid pharmaceutical composition containing an erythropoietin derivative |
| 04/27/2005 | EP1525881A2 Integrative protein-DNA cochleate fomulations and methods for transforming cells |
| 04/27/2005 | EP1525798A2 Carbohydrate oxidase and use thereof in baking |
| 04/27/2005 | EP1525483A2 Differential labeling for quantitative analysis of complex protein mixtures by trifunctional synthetic peptide based reagents with iodacetamido groups |
| 04/27/2005 | EP1525481A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 04/27/2005 | EP1525478A2 SHIGA TOXIN B-SUBUNIT AS A VECTOR FOR TUMOR DIAGNOSIS AND DRUG DELIVERY TO GB sb 3 /sb EXPRESSING TUMORS |
| 04/27/2005 | EP1525466A2 Transgenic mammals expressing polyglutamine |
| 04/27/2005 | EP1525465A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 04/27/2005 | EP1525323A2 Pgc-beta, a novel pgc-1 homologue and uses therefor |
| 04/27/2005 | EP1525316A2 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 04/27/2005 | EP1525314A2 Multi-reporter gene model for toxicological screening |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525312A2 Brachyspira hyodysenteriae vaccine |
| 04/27/2005 | EP1525311A2 Protein complexes of the tip60 transcriptional activator protein as well as components, fragments and derivatives thereof and methods for using the same |
| 04/27/2005 | EP1525306A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 04/27/2005 | EP1525302A2 Novel essential fungal polynucleotides, polypeptides, and methods of use |
| 04/27/2005 | EP1525222A1 Novel albumins |
| 04/27/2005 | EP1525221A1 Conjugate of notch signalling pathway modulators and their use in medical treatment |
| 04/27/2005 | EP1525220A1 Splice variant cannabinoid receptor (cb1b) |